You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hiltonol

Showing 1 - 25 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID - 19 Trial in Calgary (Poly-ICLC (Hiltonol®) or Placebo)

Recruiting
  • COVID - 19
  • Poly-ICLC (Hiltonol®) or Placebo
  • Calgary, Alberta, Canada
    Health Research Innovation Centre
Mar 31, 2022

Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

Completed
  • Prostate Cancer
  • Intratumoral (IT) Poly ICLC 0.5 mg
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2022

Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

Recruiting
  • Malignant Pleural Mesothelioma
  • Safety
  • Expansion Cohort
  • New York, New York
    Icahn School of Medicine Mount Sinai
Mar 31, 2022

Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

Not yet recruiting
  • Stage IV NSCLC
  • Houston, Texas
    Michael E. DeBakey VA Medical Center, Houston, TX
Sep 28, 2023

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide

Recruiting
  • Pancreas Cancer
  • +2 more
  • Optimized neoantigen synthetic long peptide vaccine
  • Poly-ICLC
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2023

Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

Not yet recruiting
  • Glioma, Malignant
  • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
  • Hiltonol
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023

High Risk Cancer, Pancreatic Cancer Trial in Baltimore (KRAS peptide vaccine)

Recruiting
  • High Risk Cancer
  • Pancreatic Cancer
  • KRAS peptide vaccine
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jun 1, 2022

Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Colorectal Cancer Metastatic
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 5, 2022

Fibrolamellar Hepatocellular Carcinoma (FLC) Trial in Baltimore (DNAJB1-PRKACA peptide vaccine, Nivolumab, Ipilimumab)

Recruiting
  • Fibrolamellar Hepatocellular Carcinoma (FLC)
  • DNAJB1-PRKACA peptide vaccine
  • +2 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)

Completed
  • Melanoma
  • DC Vaccine
  • +2 more
  • New York, New York
  • +1 more
Sep 13, 2022

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (biological, drug, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Baltimore, Maryland
  • +1 more
Mar 15, 2022

Triple Negative Breast Cancer, Triple Negative Breast Tumors, Triple-Negative Breast Cancer Trial (Personalized synthetic long

Withdrawn
  • Triple Negative Breast Cancer
  • +2 more
  • Personalized synthetic long peptide vaccine (Poly ICLC)
  • Poly ICLC
  • (no location specified)
Mar 9, 2022

Solid Cancer Trial in Chevy Chase, Easton, New York (Poly-ICLC combination treatment with aPD-1 (Nivolumab or Pembrolizumab) or

Terminated
  • Solid Cancer
  • Poly-ICLC combination treatment with aPD-1 (Nivolumab or Pembrolizumab) or aPD-L1 (Atezolizumab or Durvalumab) over 6 months
  • Chevy Chase, Maryland
  • +2 more
Jan 27, 2021

Melanoma, Head Neck Cancer, Sarcoma Trial in United States (Hiltonol)

Completed
  • Melanoma
  • +3 more
  • Hiltonol
  • Chevy Chase, Maryland
  • +4 more
Dec 15, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Pediatric Brain Tumor Trial (biological, drug, procedure)

Withdrawn
  • Pediatric Brain Tumor
  • Personalized peptide vaccine
  • +2 more
  • (no location specified)
May 21, 2021

Recurrent Glioblastoma Trial in Los Angeles (biological, other, drug)

Recruiting
  • Recurrent Glioblastoma
  • Dendritic Cell Tumor Cell Lysate Vaccine
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022

Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 18, 2021

Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Diffuse Hemispheric Glioma, H3 G34-Mutant
  • Dendritic Cell Tumor Peptide Vaccine
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022

Solid Tumors Trial in New York (Peptides, Poly-ICLC, Lenalidomide)

Completed
  • Solid Tumors
  • Peptides
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jan 7, 2021

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Melanoma Trial in Boston (Poly-ICLC, Peptides)

Completed
  • Melanoma
  • Poly-ICLC
  • Peptides
  • Boston, Massachusetts
  • +1 more
Dec 7, 2020

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial in Miami (drug, biological, other)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer
  • Miami, Florida
    University of Miami
Jun 10, 2021

Breast Cancer Trial in Tampa, Boston, New York (PVX-410, Durvalumab, Hiltonol)

Active, not recruiting
  • Breast Cancer
  • PVX-410
  • +2 more
  • Tampa, Florida
  • +4 more
May 7, 2021